RU94012930A - Новые 1-н-индол-3-ацетамиды как ингибиторы spla2 и фармацевтическая композиция на их основе - Google Patents

Новые 1-н-индол-3-ацетамиды как ингибиторы spla2 и фармацевтическая композиция на их основе

Info

Publication number
RU94012930A
RU94012930A RU94012930/04A RU94012930A RU94012930A RU 94012930 A RU94012930 A RU 94012930A RU 94012930/04 A RU94012930/04 A RU 94012930/04A RU 94012930 A RU94012930 A RU 94012930A RU 94012930 A RU94012930 A RU 94012930A
Authority
RU
Russia
Prior art keywords
acetamides
indol
basis
new
pharmaceutical composition
Prior art date
Application number
RU94012930/04A
Other languages
English (en)
Other versions
RU2162463C2 (ru
Inventor
Джеймс Бах Николас
Дилейн Диллард Роберт
Элизабет Драхайм Сюзан
Белл Херманн Роберт
Уолтер Шевиц Ричард
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of RU94012930A publication Critical patent/RU94012930A/ru
Application granted granted Critical
Publication of RU2162463C2 publication Critical patent/RU2162463C2/ru

Links

Claims (1)

  1. Представлен принципиально новый класс IH-индол-З-ацетамидов, рассмотрено их использование для ингибирования высвобождения жирных кислот, контролируемого SPLA2 для лечения условий подобных септическому шоку.
RU94012930/04A 1993-04-16 1994-04-15 Новые 1н-индол-3-ацетамиды как ингибиторы spla2 и фармацевтическая композиция на их основе RU2162463C2 (ru)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4862993A 1993-04-16 1993-04-16
US08/048629 1993-04-16
US08/048,629 1993-04-16
US20872194A 1994-03-15 1994-03-15
US08/208,721 1994-03-15
US08/208721 1994-03-15

Publications (2)

Publication Number Publication Date
RU94012930A true RU94012930A (ru) 1995-12-20
RU2162463C2 RU2162463C2 (ru) 2001-01-27

Family

ID=26726342

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94012930/04A RU2162463C2 (ru) 1993-04-16 1994-04-15 Новые 1н-индол-3-ацетамиды как ингибиторы spla2 и фармацевтическая композиция на их основе

Country Status (25)

Country Link
US (1) US5684034A (ru)
EP (1) EP0620215B1 (ru)
JP (1) JPH0725850A (ru)
KR (1) KR100317755B1 (ru)
CN (1) CN1068588C (ru)
AT (1) ATE183503T1 (ru)
AU (1) AU676884B2 (ru)
BR (1) BR9401482A (ru)
CA (1) CA2121323A1 (ru)
CO (1) CO4230092A1 (ru)
CZ (1) CZ289750B6 (ru)
DE (1) DE69420068T2 (ru)
DK (1) DK0620215T3 (ru)
ES (1) ES2138648T3 (ru)
FI (1) FI941767A (ru)
GR (1) GR3031783T3 (ru)
HU (1) HUT70836A (ru)
IL (1) IL109311A0 (ru)
NO (1) NO300732B1 (ru)
NZ (1) NZ260298A (ru)
PL (1) PL181319B1 (ru)
RU (1) RU2162463C2 (ru)
TW (1) TW268942B (ru)
UA (1) UA44218C2 (ru)
YU (1) YU20194A (ru)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
US6252084B1 (en) 1994-03-15 2001-06-26 Eli Lilly And Company 1H-indole-3-acetamide sPLA2 inhibitors
CN1067054C (zh) * 1994-04-01 2001-06-13 伊莱利利公司 1H-吲哚-3-乙醛酰胺sPLA2抑制剂
US6214876B1 (en) 1994-07-21 2001-04-10 Eli Lilly And Company Indene-1-acetamide sPLA2 inhibitors
US5641800A (en) * 1994-07-21 1997-06-24 Eli Lilly And Company 1H-indole-1-functional sPLA2 inhibitors
AU717430B2 (en) * 1996-08-26 2000-03-23 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6630496B1 (en) 1996-08-26 2003-10-07 Genetics Institute Llc Inhibitors of phospholipase enzymes
US6713645B1 (en) * 1996-10-30 2004-03-30 Eli Lilly And Company Substituted tricyclics
TR199900956T2 (xx) * 1996-10-30 1999-07-21 Eli Lilly And Company S�bstit�e edilmi� trisiklik bile�imler.
US6569539B2 (en) 1996-10-30 2003-05-27 Tetra Level Holdings & Finance S.A. Gas barrier packaging laminate method for production thereof and packaging containers
US5919774A (en) * 1996-12-10 1999-07-06 Eli Lilly And Company Pyrroles as sPLA2 inhibitors
WO1998037069A1 (fr) * 1997-02-20 1998-08-27 Shionogi & Co., Ltd. Derives d'acide indoldicarboxylique
ID26123A (id) * 1998-02-25 2000-11-23 Genetics Inst Penghambat-penghambat phospholipase a2
CN1310706A (zh) * 1998-02-25 2001-08-29 遗传研究所有限公司 磷脂酶抑制剂
US6916841B2 (en) 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6828344B1 (en) 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
JP2002504539A (ja) * 1998-02-25 2002-02-12 ジェネティックス・インスチチュート・インコーポレーテッド ホスホリパーゼ酵素の阻害剤
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
KR20010042307A (ko) 1998-03-31 2001-05-25 시오노 요시히코 피롤로[1,2-ａ]피라진 ｓＰＬＡ2 억제제
ID23219A (id) * 1998-04-17 2000-03-30 Lilly Co Eli Trisiklik tersubstitusi
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
EP1085021A4 (en) 1998-05-21 2003-01-08 Shionogi & Co DERIVATIVES OF PYRROLO 1,2-B] PYRIDAZINE, WITH INHIBITOR EFFECT ON SPLA 2?
EP1100493A4 (en) * 1998-08-03 2001-10-24 Lilly Co Eli SPLA 2 INHIBITORS? OF THE INDOLTYPS
WO2000007590A1 (en) 1998-08-03 2000-02-17 Eli Lilly And Company INDOLE sPLA2 INHIBITORS
US6325991B1 (en) 1998-08-24 2001-12-04 Susan E. Draheim Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase A2
ATE329619T1 (de) 1998-10-14 2006-07-15 Shionogi & Co Spla2-inhibitoren zur behandlung von ischämischen reperfusionsschäden
US6448284B1 (en) 1998-12-22 2002-09-10 Eli Lilly And Company Substituted tricyclics
AU6015600A (en) 1999-07-19 2001-02-05 Shionogi & Co., Ltd. Tricyclic compounds having spla2-inhibitory activities
DE60032774D1 (de) * 1999-07-19 2007-02-15 Lilly Co Eli Spla2 inhibitoren
US6706752B1 (en) 1999-07-19 2004-03-16 Eli Lilly And Company sPLA2 inhibitors
JP4636522B2 (ja) 1999-08-02 2011-02-23 塩野義製薬株式会社 ｓＰＬＡ２阻害作用を有する三環式化合物
WO2001014378A1 (fr) 1999-08-23 2001-03-01 Shionogi & Co., Ltd. DERIVES DE PYRROLOTRIAZINE A ACTIVITES INHIBANT sPLA¿2?
AU7053700A (en) * 1999-09-20 2001-04-24 Eli Lilly And Company Novel spla2 inhibitors
US6831095B1 (en) 1999-09-20 2004-12-14 Eli Lilly And Company Hydroxyfunctional amide 1h-indole derivatives active as sPLA2 inhibitors
AU7559600A (en) * 1999-10-15 2001-04-23 Shionogi & Co., Ltd. V type and/or x type spla2 inhibitors
WO2001036420A1 (fr) 1999-11-15 2001-05-25 Shionogi & Co., Ltd. Derives d'aza-indolizine tricyclique ayant un effet inhibiteur sur spla¿2?
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
US6608059B1 (en) 2000-06-27 2003-08-19 Smithkline Beecham Corporation Fatty acid synthase inhibitors
AU2001267823A1 (en) * 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
US6967200B2 (en) 2000-06-29 2005-11-22 Shionogi & Co., Ltd. Remedies for cirrhosis
US20050203166A1 (en) * 2000-06-30 2005-09-15 Cancer Research Technology Limited Indole-3-acetic acid derivatives
GB0016162D0 (en) * 2000-06-30 2000-08-23 Cancer Res Campaign Tech Indole-3-acetic acid derivatives
CN1450893A (zh) * 2000-07-14 2003-10-22 伊莱利利公司 治疗脓毒症的方法
AU2001282410A1 (en) * 2000-08-24 2002-03-22 Dublin City University N-benzylindole-3-acetic acid derivatives for use in the treatment of drug resistan cancer
CA2431506A1 (en) * 2000-12-18 2002-07-25 Eli Lilly And Company Benz(g) indoles and their use as spla2 inhibitors
EP1349834A2 (en) * 2000-12-18 2003-10-08 Eli Lilly And Company Cycloalkyfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
TWI314457B (ru) * 2001-03-19 2009-09-11 Shionogi & Co
US7101875B2 (en) 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US6797708B2 (en) 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US6984735B2 (en) 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US6635771B2 (en) 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
US7129264B2 (en) * 2003-04-16 2006-10-31 Bristol-Myers Squibb Company Biarylmethyl indolines and indoles as antithromboembolic agents
US20070161698A1 (en) * 2003-05-30 2007-07-12 Microbia, Inc. Modulators of CRTH2 Activity
JP2007527397A (ja) * 2003-07-01 2007-09-27 マイクロバイア インコーポレイテッド Ｃｏｘ−２及びｆａａｈ阻害剤
US20070293542A1 (en) * 2003-10-16 2007-12-20 Cali Brian M Selective Cox-2 Inhibitors
US7417063B2 (en) * 2004-04-13 2008-08-26 Bristol-Myers Squibb Company Bicyclic heterocycles useful as serine protease inhibitors
US20050234244A1 (en) * 2004-04-20 2005-10-20 Wilmin Bartolini Synthesis of COX-2 and FAAH inhibitors
US20050234030A1 (en) * 2004-04-20 2005-10-20 Wilmin Bartolini Modulators of CRTH2, COX-2 and FAAH
GT200600228A (es) 2005-05-27 2006-12-26 Inhibidores de la fosfolipasa a2 citosolica
WO2007022501A2 (en) * 2005-08-18 2007-02-22 Microbia, Inc. Useful indole compounds
MX2008005666A (es) 2005-11-03 2009-03-02 Ilypsa Inc Compuestos multivalentes de indol y uso de los mismos como inhibidores de fosfolipasa-a2.
WO2007056275A2 (en) * 2005-11-03 2007-05-18 Ilypsa, Inc. Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8048880B2 (en) * 2007-05-03 2011-11-01 Anthera Pharmaceuticals, Inc. Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies
EP2424521A4 (en) 2009-04-29 2015-03-04 Amarin Pharmaceuticals Ie Ltd PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND CARDIOVASCULAR AGENT AND METHODS OF USE
CN105384619B (zh) * 2014-08-22 2020-05-29 四川海思科制药有限公司 一种异丙基苯酚衍生物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2825734A (en) * 1955-04-11 1958-03-04 Upjohn Co Reduction of carbonylic radicals in indolyl-3 compounds
US2890223A (en) * 1956-03-22 1959-06-09 Research Corp 1-benzyl, 2-methyl, 5-methoxy tryptamine
US3242193A (en) * 1961-03-13 1966-03-22 Merck & Co Inc Indolyl aliphatic acids
US3242163A (en) * 1961-03-13 1966-03-22 Merck & Co Inc Indolyl aliphatic acids
US3196162A (en) * 1961-03-13 1965-07-20 Merck & Co Inc Indolyl aliphatic acids
US3242162A (en) * 1961-03-13 1966-03-22 Merck & Co Inc Indolyl aliphatic acids
US3271416A (en) * 1961-10-24 1966-09-06 Merck & Co Inc Indolyl aliphatic acids
US3259622A (en) * 1962-09-07 1966-07-05 Merck & Co Inc 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids
US4428962A (en) * 1981-10-30 1984-01-31 Schering Corporation Indoles in treatment of peptic ulcers
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors

Similar Documents

Publication Publication Date Title
RU94012930A (ru) Новые 1-н-индол-3-ацетамиды как ингибиторы spla2 и фармацевтическая композиция на их основе
EP1081135A3 (en) 1H-indole-3-glyoxylamide spla2 inhibitors
RU94012931A (ru) Гидразиды 1н-индол-3-уксусной кислоты как ингибиторы spla2
CO4230092A1 (es) 1H-INDOL-3-ACETAMIDAS INHIBIDORES DE sPLA2
BR9508298A (pt) Inibidores de indolizina de spla2
IT1237793B (it) Composti attivi come inibitori dell'enzima hmg-coa reduttasi
DE69724009D1 (de) PYRROLE ALS sPLA2 INHIBITOREN
DZ2448A1 (fr) Sel du dérivé d'acide de naphthyridine carboxylique.
MX9804751A (es) Naftil acetamidas como inhibidores de la spla2.
EP1100492A4 (en) SPLA 2 INHIBITORS? INDOLE TYPE
IL130201A0 (en) Phenyl glyoxamides as spla2 inhibitors
IT1237792B (it) Composti attivi come inibitori dell'enzima hmg-coa reduttasi
ATE247119T1 (de) Substituierte pyrroloindole
RU97117486A (ru) Средство для уничтожения пресноводных моллюсков
RU96115369A (ru) Пара-оксифенилуксусная кислота и/или ее соль в качестве средства для снижения отпугивающего действия инсектицидов
ITMI921854A0 (it) Composti attivi come inibitori dell'enzima hmg-coa reduttasi